Question 1

What are the key details for the project “Cell and Gene Therapy (CGT) Access Model”?

Accepted Answer

The project “Cell and Gene Therapy (CGT) Access Model” is an infrastructure initiative in the Government sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Question 2

What is the latest status of the project “Cell and Gene Therapy (CGT) Access Model”?

Accepted Answer

The status recorded for “Cell and Gene Therapy (CGT) Access Model” is closed.

Question 3

Who are the main government, EPC, and private stakeholders for “Cell and Gene Therapy (CGT) Access Model”?

Accepted Answer

Taiyo maps the stakeholders of “Cell and Gene Therapy (CGT) Access Model”: government bodies (Centers for Medicare & Medicaid Services, US Department of Health and Human Services (HHS), US Government).

Question 4

What is the budget and commercial profile for the project “Cell and Gene Therapy (CGT) Access Model”?

Accepted Answer

Taiyo normalizes the budget of “Cell and Gene Therapy (CGT) Access Model” to USD 95500000.

Question 5

Where can I verify the source and access all details for “Cell and Gene Therapy (CGT) Access Model”?

Accepted Answer

This Taiyo project page references Grants.gov along with the original URL (https://www.grants.gov/web/grants/view-opportunity.html?oppId=354875). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	closed
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	This Notice of Funding Opportunity (NOFO) announces the opportunity to apply for Cooperative Agreement funding to support States participation in the Cell and Gene Therapy (CGT) Access Model (the CGT Access Model or the Model). Eligible applicants are States, the District of Columbia, and any U.S. territory that participates in the Medicaid Drug Rebate Program (MDRP). A maximum of $9.55 million may be awarded to each Recipient, depending on the number of States that apply for funding, pending availability of funds.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Cell and Gene Therapy (CGT) Access Model

Project Information FAQ

Project Information